Map Key
Generic Enzyme
Generic kinase
Protein kinase
Lipid kinase
Generic phosphatase
Protein phosphatase
Lipid phosphatase
Generic phospholipase
Generic protease
Metalloprotease
G-alpha
RAS - superfamily
G beta/gamma
Regulators (GDI, GAP, GEF)
Generic channel
Ligand-gated channel
Voltage-gated channel
Transporter
Normal process
Pathological process
Positive effect
Negative effect
Unspecified effect
Technical link
Disrupts in disease
Emerges in disease
Enhances in disease
Weakens in disease
Organsim specific interaction

Generic binding protein
Receptor ligand
Cell membrane glycoprotein
Transcription factor
DNA
RNA
Compound
Inorganic ion
Predicted metabolite or user's structure
Reaction
Generic receptor
GPCR
Receptors with enzyme activity
Mitochondria
EPR
Golgi
Nucleus
Lysosome
Peroxisome
Cytoplasm
Extracellular

Normal process
Pathological process
Binding
Cleavage
Covalent modifications
Phosphorylation
Dephosphorylation
Transformation
Transport
Catalysis
Transcription regulation
MicroRNA binding
Competition
Influence on expression
Unspecified interactions
Pharmacological effect
Toxic effect
Group relation
Complex subunit
Similarity reaction
A complex or a group
Organism specific object

Translation Insulin regulation of translation


Log In to Post A Comment

Translation Insulin regulation of translation

Insulin regulation of translation.

Insulin plays an important role in the overall regulation of protein synthesis.Protein synthesis (mRNA translation) is conventionally divided into three stages:initiation, elongation and termination. Both initiation and elongation can be controlledby Insulin.

Insulin binds to Iinsulin receptors and rapidly activates proteinsynthesis by activating components of the translational system, including eIFs(eukaryotic initiation factors) and eEFs (eukaryotic elongation factors) [1].

The activation of protein synthesis by Insulin is mediated primarily throughPhosphoinositide 3-kinase ( PI3K ). This involves the activation of v-akt murinethymoma viral oncogene homolog 1 ( AKT(PKB) ) where AKT(PKB) phosphorylatesand inactivates Glycogen synthase kinase 3 beta ( GSK3 beta ), which in turnphosphorylates and inhibits subunit of eIF2B complex - Eukaryotic translationinitiation factor 2B, subunit 5 epsilon, 82kDa ( eIF2B5 ). Initiation factoreIF2B mediates the recycling of Eukaryotic translation initiation factor 2 (eIF2 ); a major player in recruiting of the initiator Met-tRNA to the ribosome.eIF2 is active when bound with GTP and forms a eIF2-GTP-Met-tRNA complex, whichbinds to the 40S ribosomal subunit. eIF2B acts by promoting the release of GDPfrom eIF2, thus allowing it to be replaced by GTP, to regenerate the activeeIF2-GTP complex. Since eIF2 is required for every initiation event,modulating the activity of eIF2B provides a mechanism for controlling overallrates of peptide-chain initiation [2], [3].

AKT(PKB) also phosphorylates and inhibits the Tuberous sclerosis 1(Hamartin )- Tuberous sclerosis 2 ( Tuberin ) complex to relieve itsinhibitory action on the FK506 binding protein 12-rapamycin associated protein 1 (mTOR ). Upon Insulin stimulation, mTOR phosphorylates Eukaryotictranslation initiation factor 4E binding protein 1 ( 4E-BP1 ) leading to theformation of an active eIF-4F complex . The eIF4F complex iscomposed of Eukaryotic translation initiation factor 4E ( eIF4E ), the cap-bindingprotein, eukaryotic translation initiation factor 4 gamma, 1 -3 ( eIF4G1/3 ), alarge polypeptide with binding sites for a number of other proteins, includingeIF4E, and an ATP-dependent RNA-helicase Eukaryotic translation initiation factor4A ( eIF4A ).

The principal mechanism utilized in the regulation of eIF4E activity is throughits interaction with a family of binding/repressor proteins termed 4E-BP1. Thebinding of 4E-BP1 to eIF4E prevents the interaction of eIF4E witheIF4G1/3 which then suppresses the formation of the eIF-4F complex. Theability of 4E-BP1 to interact with eIF4E is controlled via thephosphorylation of 4E-BP1 [4].

Insulin induces activation of Eukaryotic translation elongation factor 2 ( eEF2) to accelerate elongation. Insulin inhibits Eukaryotic elongation factor-2 kinase( eEF2K ) via v-Ha-ras Harvey rat sarcoma viral oncogene homolog ( H-Ras )/Mitogen-activated protein kinase 1-3 ( ERK1/2 ) and/or PI3K/AKT(PKB) pathways and abolish inhibitory action eEF2K on eEF2.eEF2 is required for the translocation step of elongation during which theribosome moves relative to the mRNA and the peptidyl-tRNA migrates from the A- to theP-site of the ribosome [1].